Robert Douglas Bruce MD, MA

Assistant Professor of Medicine (AIDS) and of Epidemiology (Microbial Diseases)

Departments & Organizations

2008 YCCI Scholars

Biomedical Ethics

Yale Medical Group

Global Health Initiative: HIV/AIDS | Infectious Diseases

School of Public Health: Heimer Lab - HIV

Internal Medicine: Viral Hepatitis Program | Infectious Diseases: AIDS Care Program

Research Interests

substance abuse/dependence; infectious diseases; HIV; Hepatitis C more...

Education

• BS, Houston Baptist University, 1993
• M.D., University of Texas at Dallas, 1997
• M.A., Yale Divinity School, 2003
• M.Sc., Yale University School of Public Health, 2008

Selected Publications

• Bruce RD, Eiserman J, Acosta A, Gote C, Lim JK, Altice FL. Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication. American Journal of Drug and Alcohol Abuse. 2012 May; 38(3):206-12.
• Bruce RD, Moody DE, Wenfang BF, Chodkowski D, Andrews L, Friedland GH. Tipranavir/Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone. American Journal of Drug and Alcohol Abuse. 2011 Jul; 37(4):224-8.
• Bruce RD, Altice FL, Moody DE, Morse GD, Andrews L, Lin S, Fang WB, Ma Q, Friedland GH. Pharmacokinetic Interactions between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir. JAIDS. 2010 Aug: 54(5):511-4. NIHMS 198833

more...